Which Weight Management Treatment Suits Your Needs?
Mounjaro vs Wegovy Dose Equivalent: Understanding the Differences
When comparing Mounjaro vs Wegovy dose equivalent options, it's important to understand these aren't directly interchangeable medications. Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist, whilst Wegovy (semaglutide) targets GLP-1 receptors exclusively. This fundamental difference means dose equivalency isn't a simple numerical comparison — each prescription-only medicine has its own distinct dosing schedule and mechanism of action.
The private prescription route at EverydayMeds eliminates the frustration of NHS waiting lists, which typically involve GP referral to specialist weight management services with 6-month delays. Our streamlined process provides access to genuine treatments within days, not months. Both Wegovy and Mounjaro are available from EverydayMeds — your prescriber can help determine which is right for you based on your medical history and weight management goals.
Transparent Pricing for Mounjaro vs Wegovy Dose Equivalent Treatments
Understanding the cost implications when comparing Mounjaro vs Wegovy dose equivalent options helps inform your treatment choice. Wegovy follows a structured escalation from 0.25mg (£79.99) through to maintenance dose 2.4mg (£209.99). Our Intro Duo bundle (0.25mg & 0.5mg) costs £169.99, providing your first two months of treatment. New customers apply code FIRST40 at checkout, whilst returning customers use DOSE25 to access these competitive rates.
The private prescription model offers transparent, all-inclusive pricing without hidden fees or lengthy NHS eligibility assessments. Each dose represents a month's supply, with clear progression pathways built into our Getting Started bundles. Our Ultimate Stability Trio provides three months of 2.4mg maintenance supply for £649.99, ensuring treatment continuity without repeated ordering. This pricing structure reflects the genuine Novo Nordisk Wegovy supply from our GPhC-registered pharmacy #9012878.
Clinical Evidence: Mounjaro vs Wegovy Dose Equivalent Efficacy
Clinical trials demonstrate both treatments can support significant weight management when used alongside a reduced-calorie diet and increased physical activity. The STEP trials showed patients taking Wegovy achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). These results were sustained at two years in STEP 5, with patients maintaining approximately 15.2% weight reduction.
When considering Mounjaro vs Wegovy dose equivalent clinical outcomes, the different receptor targets may influence individual response patterns. However, comparing trial weight loss percentages directly isn't appropriate due to different study designs and patient populations. Your prescriber will consider your medical history, current medications, and treatment goals when recommending between these prescription-only medicines.
How Wegovy Works: GLP-1 Receptor Mechanism
Wegovy functions as a GLP-1 receptor agonist, mimicking a natural fullness hormone produced in your intestines. This mechanism reduces appetite by acting on brain appetite centres, promoting earlier satiety after smaller meals and potentially reducing food cravings throughout the day. The once-weekly injection provides sustained hormone levels, supporting consistent appetite regulation between doses. Unlike rapid-acting appetite suppressants, Wegovy's mechanism works gradually to retrain eating patterns and portion control. This approach supports sustainable lifestyle changes rather than temporary appetite suppression, making it particularly effective when combined with dietary counselling and increased physical activity.
Private Prescription Ordering Process
Accessing Wegovy through EverydayMeds involves a comprehensive 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Our qualified prescribers review applications within 3 working days (or 24 hours with express service), ensuring thorough safety evaluation before approval. Once prescribed, your Wegovy is dispatched via next-day cold-chain delivery, maintaining the required 2-8°C temperature throughout transit. Each FlexTouch pen arrives with detailed injection guidance and dose escalation schedules, supporting safe self-administration from week one. This streamlined process eliminates GP appointments and specialist referrals whilst maintaining rigorous clinical oversight.
Storage and Practical Considerations
Wegovy requires refrigeration at 2-8°C before first use, but offers superior travel convenience with 6 weeks room temperature storage below 30°C once removed from the fridge. This storage advantage over Mounjaro's 21-day room temperature limit makes Wegovy particularly suitable for business travellers or extended holidays. The FlexTouch pen design provides accurate dosing with clear visual confirmation of injection completion. Dose escalation follows a mandatory 4-week schedule: 0.25mg, 0.5mg, 1mg, 1.7mg, then maintenance 2.4mg — skipping doses isn't recommended as it increases gastrointestinal side effects. Each pen contains 4 weekly doses, with clear remaining dose indicators preventing accidental under-dosing.
Mounjaro vs Wegovy Dose Equivalent: Dual vs Single Receptor Targeting
The key distinction when evaluating Mounjaro vs Wegovy dose equivalent treatments lies in receptor selectivity rather than simple dose conversion. Wegovy's selective GLP-1 targeting provides proven cardiovascular benefits, with the SELECT trial demonstrating 20% reduction in major cardiovascular events. This established safety profile makes Wegovy particularly suitable for patients with existing heart conditions or diabetes risk factors.
Mounjaro's dual GIP/GLP-1 mechanism represents newer technology with potentially different side effect profiles and efficacy patterns. However, the longer-term cardiovascular safety data available for Wegovy may influence prescriber preferences, particularly for patients requiring extended treatment duration. Your EverydayMeds prescriber will evaluate these mechanistic differences against your individual cardiovascular risk profile when recommending treatment options.
Start Your Weight Management Journey Today
Ready to explore whether Wegovy suits your weight management goals? Our clinical team provides expert guidance on Mounjaro vs Wegovy dose equivalent considerations through comprehensive prescriber consultations. New customers benefit from code FIRST40, whilst returning patients use DOSE25 at checkout for competitive pricing across all dose strengths. Begin with our 3-minute assessment to determine eligibility and receive personalised treatment recommendations from our GPhC-registered pharmacy #9012878. Next-day delivery ensures rapid treatment initiation once approved, supporting your commitment to sustainable weight management. Contact our clinical team today to discuss which prescription-only medicine aligns with your health goals and lifestyle requirements.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
